144 related articles for article (PubMed ID: 18852415)
1. Correlation of nonsense and frameshift mutations with severity of retinal abnormalities in neurofibromatosis 2.
Feucht M; Kluwe L; Mautner VF; Richard G
Arch Ophthalmol; 2008 Oct; 126(10):1376-80. PubMed ID: 18852415
[TBL] [Abstract][Full Text] [Related]
2. Germ-line mutations in the neurofibromatosis 2 gene: correlations with disease severity and retinal abnormalities.
Parry DM; MacCollin MM; Kaiser-Kupfer MI; Pulaski K; Nicholson HS; Bolesta M; Eldridge R; Gusella JF
Am J Hum Genet; 1996 Sep; 59(3):529-39. PubMed ID: 8751853
[TBL] [Abstract][Full Text] [Related]
3. Neurofibromatosis 2 leads to choroidal hyperfluorescence in fluorescein angiography.
Feucht M; Richard G; Mautner VF
Graefes Arch Clin Exp Ophthalmol; 2007 Jul; 245(7):949-53. PubMed ID: 17186263
[TBL] [Abstract][Full Text] [Related]
4. Further genotype--phenotype correlations in neurofibromatosis 2.
Selvanathan SK; Shenton A; Ferner R; Wallace AJ; Huson SM; Ramsden RT; Evans DG
Clin Genet; 2010 Feb; 77(2):163-70. PubMed ID: 19968670
[TBL] [Abstract][Full Text] [Related]
5. [Phenotype-genotype study in 154 French NF2 mutation carriers].
Demange L; De Moncuit C; Thomas G; Olschwang S
Rev Neurol (Paris); 2007 Nov; 163(11):1031-8. PubMed ID: 18033041
[TBL] [Abstract][Full Text] [Related]
6. Genotype-phenotype correlations for nervous system tumors in neurofibromatosis 2: a population-based study.
Baser ME; Kuramoto L; Joe H; Friedman JM; Wallace AJ; Gillespie JE; Ramsden RT; Evans DG
Am J Hum Genet; 2004 Aug; 75(2):231-9. PubMed ID: 15190457
[TBL] [Abstract][Full Text] [Related]
7. Identification of NF2 germ-line mutations and comparison with neurofibromatosis 2 phenotypes.
Kluwe L; Bayer S; Baser ME; Hazim W; Haase W; Fünsterer C; Mautner VF
Hum Genet; 1996 Nov; 98(5):534-8. PubMed ID: 8882871
[TBL] [Abstract][Full Text] [Related]
8. Type of mutation in the neurofibromatosis type 2 gene (NF2) frequently determines severity of disease.
Ruttledge MH; Andermann AA; Phelan CM; Claudio JO; Han FY; Chretien N; Rangaratnam S; MacCollin M; Short P; Parry D; Michels V; Riccardi VM; Weksberg R; Kitamura K; Bradburn JM; Hall BD; Propping P; Rouleau GA
Am J Hum Genet; 1996 Aug; 59(2):331-42. PubMed ID: 8755919
[TBL] [Abstract][Full Text] [Related]
9. Intrafamilial correlation of clinical manifestations in neurofibromatosis 2 (NF2).
Zhao Y; Kumar RA; Baser ME; Evans DG; Wallace A; Kluwe L; Mautner VF; Parry DM; Rouleau GA; Joe H; Friedman JM
Genet Epidemiol; 2002 Oct; 23(3):245-59. PubMed ID: 12384977
[TBL] [Abstract][Full Text] [Related]
10. [Retinal Astrocytic Hamartoma in Neurofibromatosis Type 2 - Metaanalysis and a Case Report].
Starosta DA; Lorenz B
Klin Monbl Augenheilkd; 2018 Mar; 235(3):290-300. PubMed ID: 29534265
[TBL] [Abstract][Full Text] [Related]
11. Phenotypic variability in two families with novel splice-site and frameshift NF2 mutations.
Mautner VF; Baser ME; Kluwe L
Hum Genet; 1996 Aug; 98(2):203-6. PubMed ID: 8698343
[TBL] [Abstract][Full Text] [Related]
12. Cranial meningiomas in 411 neurofibromatosis type 2 (NF2) patients with proven gene mutations: clear positional effect of mutations, but absence of female severity effect on age at onset.
Smith MJ; Higgs JE; Bowers NL; Halliday D; Paterson J; Gillespie J; Huson SM; Freeman SR; Lloyd S; Rutherford SA; King AT; Wallace AJ; Ramsden RT; Evans DG
J Med Genet; 2011 Apr; 48(4):261-5. PubMed ID: 21278391
[TBL] [Abstract][Full Text] [Related]
13. Intramedullary and spinal canal tumors in patients with neurofibromatosis 2: MR imaging findings and correlation with genotype.
Patronas NJ; Courcoutsakis N; Bromley CM; Katzman GL; MacCollin M; Parry DM
Radiology; 2001 Feb; 218(2):434-42. PubMed ID: 11161159
[TBL] [Abstract][Full Text] [Related]
14. Age related shift in the mutation spectra of germline and somatic NF2 mutations: hypothetical role of DNA repair mechanisms.
Evans DG; Maher ER; Baser ME
J Med Genet; 2005 Aug; 42(8):630-2. PubMed ID: 16061561
[TBL] [Abstract][Full Text] [Related]
15. The location of constitutional neurofibromatosis 2 (NF2) splice site mutations is associated with the severity of NF2.
Baser ME; Kuramoto L; Woods R; Joe H; Friedman JM; Wallace AJ; Ramsden RT; Olschwang S; Bijlsma E; Kalamarides M; Papi L; Kato R; Carroll J; Lázaro C; Joncourt F; Parry DM; Rouleau GA; Evans DG
J Med Genet; 2005 Jul; 42(7):540-6. PubMed ID: 15994874
[TBL] [Abstract][Full Text] [Related]
16. Combined retinal hamartomas leading to the diagnosis of neurofibromatosis type 2.
Grant EA; Trzupek KM; Reiss J; Crow K; Messiaen L; Weleber RG
Ophthalmic Genet; 2008 Sep; 29(3):133-8. PubMed ID: 18766994
[TBL] [Abstract][Full Text] [Related]
17. Severe phenotype of neurofibromatosis type 2 in a patient with a 7.4-MB constitutional deletion on chromosome 22: possible localization of a neurofibromatosis type 2 modifier gene?
Bruder CE; Ichimura K; Blennow E; Ikeuchi T; Yamaguchi T; Yuasa Y; Collins VP; Dumanski JP
Genes Chromosomes Cancer; 1999 Jun; 25(2):184-90. PubMed ID: 10338003
[TBL] [Abstract][Full Text] [Related]
18. Ocular alterations, molecular findings, and three novel pathological mutations in a series of NF2 patients.
Waisberg V; Rodrigues LOC; Nehemy MB; Bastos-Rodrigues L; de Miranda DM
Graefes Arch Clin Exp Ophthalmol; 2019 Jul; 257(7):1453-1458. PubMed ID: 31089872
[TBL] [Abstract][Full Text] [Related]
19. Impairment of cell adhesion by expression of the mutant neurofibromatosis type 2 (NF2) genes which lack exons in the ERM-homology domain.
Koga H; Araki N; Takeshima H; Nishi T; Hirota T; Kimura Y; Nakao M; Saya H
Oncogene; 1998 Aug; 17(7):801-10. PubMed ID: 9779996
[TBL] [Abstract][Full Text] [Related]
20. Neurofibromatosis 2 phenotypes and germ-line NF2 mutations determined by an RNA mismatch method and loss of heterozygosity analysis in NF2 schwannomas.
Hung G; Faudoa R; Baser ME; Xue Z; Kluwe L; Slattery W; Brackman D; Lim D
Cancer Genet Cytogenet; 2000 Apr; 118(2):167-8. PubMed ID: 10748301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]